| NFI schedules second quarter 2026 financial results and conference call |
Globe Newswire |
06/25 |
07:30 |
| Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management |
Globe Newswire |
06/25 |
07:30 |
| NuCube Energy to Become a Publicly Listed Company Through Business Combination with Launch Two Acquisition Corp. |
Globe Newswire |
06/25 |
07:20 |
| Digital Currency X Technology Enters Into Securities Purchase Agreement for a Private Placement of US$700 Million of Units, Payable in U.S. Dollars or Digital Assets, to Advance Its Digital Asset Treasury Strategy |
Globe Newswire |
06/25 |
07:18 |
| Winnebago Industries Reports Third Quarter Fiscal 2026 Results |
Globe Newswire |
06/25 |
07:00 |
| Kymera Therapeutics Completes Enrollment in the Phase 2b BROADEN2 Trial of KT-621 in Atopic Dermatitis with Topline Data by Year-end 2026 |
Globe Newswire |
06/25 |
07:00 |
| Calgon Carbon Wins AWWA Innovation Award for PFAS Destruction Breakthrough |
Globe Newswire |
06/25 |
07:00 |
| Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial |
Globe Newswire |
06/25 |
07:00 |
| Initial Lightbridge Fuel™ Material Samples Removed from Idaho National Laboratory’s Advanced Test Reactor |
Globe Newswire |
06/25 |
07:00 |
| Herantis appoints experienced drug development expert Dr Juha Savola as Chief Medical Officer |
Globe Newswire |
06/25 |
07:00 |
| Seres Therapeutics to Host Webcast on July 8, 2026, to Discuss Results of Investigator-Sponsored Trial of Seres’ SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis |
Globe Newswire |
06/25 |
07:00 |
| NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System |
Globe Newswire |
06/25 |
07:00 |
| Baker Hughes to Deliver Subsea Production Systems to Support Azule Energy’s Greater PAJ Development |
Globe Newswire |
06/25 |
07:00 |
| Adobe Introduces Firefly Foundry to Support Custom AI Models for Enterprise Brand Consistency |
Globe Newswire |
06/25 |
06:42 |
| Leads Biolabs Announces Partner Oblenio Bio’s $62 Million Oversubscribed Series B Financing to Advance Tri-Specific T-Cell Engager LBL‑051 for Autoimmune Diseases into Clinical Development |
Globe Newswire |
06/25 |
06:38 |
| ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement |
Globe Newswire |
06/25 |
06:35 |
| WidePoint Named Single Awardee of the $3.1 Billion DHS CWMS 3.0 Contract |
Globe Newswire |
06/25 |
06:30 |
| WeRide GENESIS Named “Generative AI Platform of the Year,” Following ATTI Simulation Innovation Award |
Globe Newswire |
06/25 |
06:25 |
| ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform |
Globe Newswire |
06/25 |
06:25 |
| Apolosign Digital Calendar and Portable TV for Family Organization and Home Entertainment |
Globe Newswire |
06/25 |
06:18 |
| Radware and Dataiku Join Forces to Secure Enterprise AI, Expanding Radware’s Role in AI Adoption |
Globe Newswire |
06/25 |
06:00 |
| DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite |
Globe Newswire |
06/25 |
06:00 |
| Beam Global Relocates Manufacturing Operations to Yuma, AZ |
Globe Newswire |
06/25 |
06:00 |
| KBR Names Chief Executive Officer and Chief Financial Officer of its Mission Technology Solutions Spin-off Business |
Globe Newswire |
06/25 |
06:00 |
| Acuity Reports Fiscal 2026 Third-Quarter Results |
Globe Newswire |
06/25 |
06:00 |
